Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079285 | SCV000111155 | uncertain significance | not provided | 2013-06-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001854400 | SCV002306501 | uncertain significance | Long QT syndrome | 2023-01-17 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 24 of the CACNA1C gene. It does not directly change the encoded amino acid sequence of the CACNA1C protein. It affects a nucleotide within the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 93400). This variant has been observed in individual(s) with clinical features of CACNA1C-related conditions (PMID: 31130284). This variant is present in population databases (rs398123520, gnomAD 0.003%). |